• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

挖掘整合生物医学数据中的关系路径。

Mining relational paths in integrated biomedical data.

机构信息

School of Library and Information Science, Indiana University, Bloomington, Indiana, United States of America.

出版信息

PLoS One. 2011;6(12):e27506. doi: 10.1371/journal.pone.0027506. Epub 2011 Dec 6.

DOI:10.1371/journal.pone.0027506
PMID:22162991
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3232205/
Abstract

Much life science and biology research requires an understanding of complex relationships between biological entities (genes, compounds, pathways, diseases, and so on). There is a wealth of data on such relationships in publicly available datasets and publications, but these sources are overlapped and distributed so that finding pertinent relational data is increasingly difficult. Whilst most public datasets have associated tools for searching, there is a lack of searching methods that can cross data sources and that in particular search not only based on the biological entities themselves but also on the relationships between them. In this paper, we demonstrate how graph-theoretic algorithms for mining relational paths can be used together with a previous integrative data resource we developed called Chem2Bio2RDF to extract new biological insights about the relationships between such entities. In particular, we use these methods to investigate the genetic basis of side-effects of thiazolinedione drugs, and in particular make a hypothesis for the recently discovered cardiac side-effects of Rosiglitazone (Avandia) and a prediction for Pioglitazone which is backed up by recent clinical studies.

摘要

许多生命科学和生物学研究都需要理解生物实体(基因、化合物、途径、疾病等)之间的复杂关系。在公开数据集和出版物中有大量关于这些关系的数据,但这些来源是重叠和分散的,以至于越来越难以找到相关的关系数据。虽然大多数公共数据集都有用于搜索的相关工具,但缺乏可以跨数据源搜索的搜索方法,特别是不仅要基于生物实体本身,还要基于它们之间的关系进行搜索的方法。在本文中,我们展示了如何将挖掘关系路径的图论算法与我们之前开发的名为 Chem2Bio2RDF 的综合数据资源结合使用,以提取有关这些实体之间关系的新生物学见解。特别是,我们使用这些方法来研究噻唑烷二酮类药物副作用的遗传基础,特别是对罗格列酮(文迪雅)最近发现的心脏副作用提出假设,并对吡格列酮进行预测,该预测得到了最近临床研究的支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee3/3232205/68db81e28ebc/pone.0027506.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee3/3232205/1b46bfd812be/pone.0027506.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee3/3232205/5374dc5dfc54/pone.0027506.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee3/3232205/18cbc73387a1/pone.0027506.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee3/3232205/381fda0e4179/pone.0027506.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee3/3232205/ab5205c3cd07/pone.0027506.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee3/3232205/68db81e28ebc/pone.0027506.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee3/3232205/1b46bfd812be/pone.0027506.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee3/3232205/5374dc5dfc54/pone.0027506.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee3/3232205/18cbc73387a1/pone.0027506.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee3/3232205/381fda0e4179/pone.0027506.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee3/3232205/ab5205c3cd07/pone.0027506.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee3/3232205/68db81e28ebc/pone.0027506.g006.jpg

相似文献

1
Mining relational paths in integrated biomedical data.挖掘整合生物医学数据中的关系路径。
PLoS One. 2011;6(12):e27506. doi: 10.1371/journal.pone.0027506. Epub 2011 Dec 6.
2
Association between extent of thiazolidinedione exposure and risk of acute myocardial infarction.噻唑烷二酮类药物暴露程度与急性心肌梗死风险之间的关联。
Pharmacotherapy. 2009 Jul;29(7):775-83. doi: 10.1592/phco.29.7.775.
3
Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies.噻唑烷二酮类药物的心血管系统比较作用:观察性研究的系统评价和荟萃分析。
BMJ. 2011 Mar 17;342:d1309. doi: 10.1136/bmj.d1309.
4
Avandia outcome may signal change in epidemiologists' sway.文迪雅的结果可能预示着流行病学家影响力的变化。
Nat Med. 2010 Jun;16(6):614. doi: 10.1038/nm0610-614a.
5
The thiazolidinediones rosiglitazone and pioglitazone and the risk of coronary heart disease: a retrospective cohort study using a US health insurance database.噻唑烷二酮类药物罗格列酮和吡格列酮与冠心病风险:一项使用美国医疗保险数据库的回顾性队列研究。
Clin Ther. 2009 Nov;31(11):2665-77. doi: 10.1016/j.clinthera.2009.11.003.
6
Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database.罗格列酮和吡格列酮在法国的药物安全性:一项使用法国药物警戒数据库的研究。
BMC Clin Pharmacol. 2011 May 24;11:5. doi: 10.1186/1472-6904-11-5.
7
Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system database.噻唑烷二酮类药物相关的心血管、眼部和骨骼不良反应:美国 FDA 不良事件报告系统数据库的比例失调分析。
Drug Saf. 2012 Apr 1;35(4):315-23. doi: 10.2165/11596510-000000000-00000.
8
[Uncertainly after publications on glitazones. Elevated myocardial infarction risk is not a class effect].[关于格列酮类药物的出版物之后存在不确定性。心肌梗死风险升高并非类效应]
MMW Fortschr Med. 2007 Dec 6;149(49-50):49-50. doi: 10.1007/BF03365260.
9
Thiazolidinediones and cardiovascular events in patients with type 2 diabetes mellitus: a retrospective cohort study of over 473,000 patients using the National Health Insurance database in Taiwan.噻唑烷二酮类药物与2型糖尿病患者的心血管事件:一项使用台湾国民健康保险数据库对超过473,000名患者进行的回顾性队列研究。
Drug Saf. 2009;32(8):675-90. doi: 10.2165/00002018-200932080-00006.
10
Rosiglitazone and cardiovascular risk.罗格列酮与心血管风险。
Curr Atheroscler Rep. 2008 Oct;10(5):398-404. doi: 10.1007/s11883-008-0062-7.

引用本文的文献

1
Understanding Drug Repurposing From the Perspective of Biomedical Entities and Their Evolution: Bibliographic Research Using Aspirin.从生物医学实体及其演变的角度理解药物再利用:以阿司匹林为例的文献研究
JMIR Med Inform. 2020 Jun 16;8(6):e16739. doi: 10.2196/16739.
2
Artificial Intelligence-Driven Structurization of Diagnostic Information in Free-Text Pathology Reports.人工智能驱动的自由文本病理报告中诊断信息的结构化
J Pathol Inform. 2020 Feb 11;11:4. doi: 10.4103/jpi.jpi_30_19. eCollection 2020.
3
Adopting Text Mining on Rehabilitation Therapy Repositioning for Stroke.

本文引用的文献

1
Finding complex biological relationships in recent PubMed articles using Bio-LDA.利用 Bio-LDA 在最近的 PubMed 文章中发现复杂的生物学关系。
PLoS One. 2011 Mar 23;6(3):e17243. doi: 10.1371/journal.pone.0017243.
2
Use of ibuprofen and risk of Parkinson disease.布洛芬的使用与帕金森病风险。
Neurology. 2011 Mar 8;76(10):863-9. doi: 10.1212/WNL.0b013e31820f2d79. Epub 2011 Mar 2.
3
Literature mining for the discovery of hidden connections between drugs, genes and diseases.文献挖掘发现药物、基因和疾病之间隐藏的关联。
将文本挖掘应用于中风康复治疗的重新定位
Front Neuroinform. 2019 Mar 19;13:17. doi: 10.3389/fninf.2019.00017. eCollection 2019.
4
Inferring Drug-Protein⁻Side Effect Relationships from Biomedical Text.从生物医学文本中推断药物-蛋白质-副作用关系。
Genes (Basel). 2019 Feb 19;10(2):159. doi: 10.3390/genes10020159.
5
UMLS to DBPedia link discovery through circular resolution.通过循环解析发现 UMLS 到 DBPedia 的链接。
J Am Med Inform Assoc. 2018 Jul 1;25(7):819-826. doi: 10.1093/jamia/ocy021.
6
An Integrated Data Driven Approach to Drug Repositioning Using Gene-Disease Associations.一种利用基因-疾病关联进行药物重新定位的综合数据驱动方法。
PLoS One. 2016 May 19;11(5):e0155811. doi: 10.1371/journal.pone.0155811. eCollection 2016.
7
Mining integrated semantic networks for drug repositioning opportunities.挖掘整合语义网络以寻找药物重新定位的机会。
PeerJ. 2016 Jan 19;4:e1558. doi: 10.7717/peerj.1558. eCollection 2016.
8
A phenome-guided drug repositioning through a latent variable model.基于潜在变量模型的表型导向药物重定位。
BMC Bioinformatics. 2014 Aug 8;15(1):267. doi: 10.1186/1471-2105-15-267.
9
A systems approach for analysis of high content screening assay data with topic modeling.基于主题建模的高通量筛选 assay 数据系统分析方法。
BMC Bioinformatics. 2013;14 Suppl 14(Suppl 14):S11. doi: 10.1186/1471-2105-14-S14-S11. Epub 2013 Oct 9.
10
Investigating drug repositioning opportunities in FDA drug labels through topic modeling.通过主题建模研究 FDA 药物标签中的药物重新定位机会。
BMC Bioinformatics. 2012;13 Suppl 15(Suppl 15):S6. doi: 10.1186/1471-2105-13-S15-S6. Epub 2012 Sep 11.
PLoS Comput Biol. 2010 Sep 23;6(9):e1000943. doi: 10.1371/journal.pcbi.1000943.
4
Cyclooxygenase and neuroinflammation in Parkinson's disease neurodegeneration.环氧化酶与帕金森病神经退行性变中的神经炎症。
Curr Neuropharmacol. 2010 Mar;8(1):62-8. doi: 10.2174/157015910790909485.
5
Chem2Bio2RDF: a semantic framework for linking and data mining chemogenomic and systems chemical biology data.Chem2Bio2RDF:一个链接和挖掘化学生物组学和系统化学生物学数据的语义框架。
BMC Bioinformatics. 2010 May 17;11:255. doi: 10.1186/1471-2105-11-255.
6
Effects of aspirin and celecoxib on rigidity in a rat model of Parkinson's disease.阿司匹林和塞来昔布对帕金森病大鼠模型僵硬症状的影响。
Pak J Biol Sci. 2007 Nov 1;10(21):3853-8. doi: 10.3923/pjbs.2007.3853.3858.
7
Bio2RDF: towards a mashup to build bioinformatics knowledge systems.Bio2RDF:迈向构建生物信息学知识系统的混搭应用程序
J Biomed Inform. 2008 Oct;41(5):706-16. doi: 10.1016/j.jbi.2008.03.004. Epub 2008 Mar 21.
8
Association of apolipoprotein E genotypes with lipid levels and coronary risk.载脂蛋白E基因分型与血脂水平及冠心病风险的关联
JAMA. 2007 Sep 19;298(11):1300-11. doi: 10.1001/jama.298.11.1300.
9
Systems chemical biology.系统化化学生物学
Nat Chem Biol. 2007 Aug;3(8):447-50. doi: 10.1038/nchembio0807-447.
10
Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications.帕金森病及其他神经退行性疾病中的炎症:病因及治疗意义
Curr Pharm Des. 2007;13(18):1925-8. doi: 10.2174/138161207780858429.